Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced...

ELUCIREM™ (gadopiclenol) Injection Safety Data Poster Presentation First Place "Image of the Year" Winner of Applied Radiology and Guerbet 'Elucirem | The Reveal Image Challenge' to be Announced...

Speaking session and poster at the 2023 American Public Health Association (APHA) conference will also highlight successful use cases from the state of Vermont CAMBRIDGE, Mass., Nov. 2, 2023...

Integrated polygenic risk score more accurately identified individuals at elevated risk for developing coronary artery disease, especially within borderline or intermediate clinical risk...

Over 3,300 executives will convene to explore solutions for various aspects of planning and managing clinical trials. NEEDHAM, Mass., Nov. 2, 2023 /PRNewswire-PRWeb/ -- In response to the rapid...